L. R. SUTHERLAND; G. Y. MINUK
This content is PDF only. Please click on the PDF icon to access.
To the editor: Recently, Ro 15-1788, a GABA-benzodiazepine receptor antagonist, was reported to be effective in the management of adults with chronic liver disease and hepatic encephalopathy (1, 2). To our knowledge, the use of this agent has not been reported in patients with fulminant hepatic failure.
A 30-year-old woman was hospitalized with nausea and abdominal discomfort after an acetaminophen overdose (15 g). Laboratory results included serum bilirubin, 67 μM/L (normal, 3 to 20) and alanine aminotransferase, 2598 U/L (normal, 0 to 36). The prothrombin time was 59.3s (control, 11 to 13). Forty-eight hours later the patient became confused, then
SUTHERLAND LR, MINUK GY. Ro 15-1788 and Hepatic Failure. Ann Intern Med. ;108:158. doi: 10.7326/0003-4819-108-1-158_1
Download citation file:
Published: Ann Intern Med. 1988;108(1):158.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use